CHEMORADIOTHERAPY

Advertisement
Dec 26 2025HEALTH

Boosting Treatment for Esophageal Cancer: A New Hope

Esophageal cancer, specifically squamous cell carcinoma, is tough to beat. Doctors usually treat it with a combo of chemotherapy, radiation, and surgery. But, even with this approach, the results aren't great. So, researchers are always looking for ways to improve treatment. One promising area is i

reading time less than a minute
May 12 2025HEALTH

Can Lung Cancer Treatment Be Safely Resumed After a Serious Side Effect?

In the treatment of lung cancer, doctors often use a combination of chemotherapy and radiation. But there is a problem. Sometimes, this mix causes a serious side effect called pneumonitis. This is when the lungs become inflamed. Pneumonitis can be bad enough to stop treatment. But what happens

reading time less than a minute
Feb 14 2025HEALTH

Cervical Cancer: A Battle with Symptoms and Self-Care

Cervical cancer is a tough battle that many women face. One of the common treatments for this type of cancer is concurrent chemoradiotherapy. This treatment combines chemotherapy and radiation therapy at the same time. It can be a challenging experience for patients. Many women face a variety of sym

reading time less than a minute
Nov 26 2024HEALTH

How Cancer Treatment Affects Daily Life for Esophageal Cancer Patients

Esophageal cancer (EC) patients undergo significant changes during and after their treatment with chemoradiotherapy. These changes include shifts in body mass index (BMI), performance status, nutrition status, symptom distress, and physical fitness. A recent study explored how these factors evolve o

reading time less than a minute
Nov 13 2024HEALTH

Could CT Scans Predict Recurrence After Anal Cancer Treatment?

It's a dicey situation for many people with anal squamous cell carcinoma (ASCC). Even after treatment with chemoradiotherapy (CRT), about 3 in 10 patients face a recurrence. Unfortunately, the current tools doctors use to predict who might relapse aren't very effective. So, a group of researchers de

reading time less than a minute